Therapeutics Company Announces Positive Trial Results For Fibro-inflammatory Disease Treatment
Chemomab Therapeutics Announces Positive Phase 2 Trial Results for CM-101 in Primary Sclerosing Cholangitis.
Disclaimer: This article is intended for informational purposes only and should not be construed as financial, medical, or investment advice. Readers should conduct their own research and consult with professional advisors before making any decisions based on the information provided herein.
Real-time information is available dail…